Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Taro Pharmaceutical (TARO)
NYSE:TARO
RESEARCH TOOLSreports
Holding TARO?
Track your performance easily
| Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | $ 130.50M | $ 156.66M | $ 143.26M | $ 138.98M |
| Gross Profit | - | $ 46.96M | $ 81.61M | $ 77.34M | $ 76.03M |
| EBIT | - | $ -6.82M | $ 13.98M | $ 21.28M | $ 36.99M |
| EBITDA | - | $ 201.00K | $ 20.95M | $ 27.94M | $ 43.45M |
| Net Income Common Stockholders | - | $ -2.81M | $ 14.08M | $ 27.40M | $ 26.31M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 730.31M | $ 839.49M | $ 806.25M | $ 820.75M | $ 787.08M |
| Total Assets | $ 2.08B | $ 2.11B | $ 2.12B | $ 2.18B | $ 2.12B |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 2.20M | $ 0.00 |
| Net Debt | $ -730.31M | $ -839.49M | $ -806.25M | $ -818.54M | $ -787.08M |
| Total Liabilities | $ 348.79M | $ 401.00M | $ 406.28M | $ 464.92M | $ 426.46M |
| Stockholders Equity | $ 1.73B | $ 1.71B | $ 1.71B | $ 1.71B | $ 1.70B |
| Cash Flow | - | ||||
| Free Cash Flow | - | $ 18.96M | $ -60.14M | $ 38.46M | $ -195.24M |
| Operating Cash Flow | - | $ 20.36M | $ -58.03M | $ 41.26M | $ -191.93M |
| Investing Cash Flow | - | $ -70.79M | $ 34.76M | $ -108.61M | $ -14.02M |
| Financing Cash Flow | - | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |